856 related articles for article (PubMed ID: 28963809)
1. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
6. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns in children with autism in the United States.
Monz BU; Houghton R; Law K; Loss G
Autism Res; 2019 Mar; 12(3):517-526. PubMed ID: 30629336
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders.
Vohra R; Madhavan S; Sambamoorthi U
Autism; 2017 Nov; 21(8):995-1009. PubMed ID: 27875247
[TBL] [Abstract][Full Text] [Related]
13. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
Jobski K; Höfer J; Hoffmann F; Bachmann C
Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
[TBL] [Abstract][Full Text] [Related]
16. State variation in psychotropic medication use by foster care children with autism spectrum disorder.
Rubin DM; Feudtner C; Localio R; Mandell DS
Pediatrics; 2009 Aug; 124(2):e305-12. PubMed ID: 19620187
[TBL] [Abstract][Full Text] [Related]
17. Characterizing psychiatric comorbidity in children with autism spectrum disorder receiving publicly funded mental health services.
Brookman-Frazee L; Stadnick N; Chlebowski C; Baker-Ericzén M; Ganger W
Autism; 2018 Nov; 22(8):938-952. PubMed ID: 28914082
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.
Pennap D; Zito JM; Santosh PJ; Tom SE; Onukwugha E; Magder LS
JAMA Pediatr; 2018 Jun; 172(6):576-584. PubMed ID: 29710205
[TBL] [Abstract][Full Text] [Related]
19. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
Kamimura-Nishimura K; Froehlich T; Chirdkiatgumchai V; Adams R; Fredstrom B; Manning P
Ann Epidemiol; 2017 Jul; 27(7):448-453.e1. PubMed ID: 28789776
[TBL] [Abstract][Full Text] [Related]
20. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
